IMM-101
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
e14627Background: The MODULATE (IMM-101-011, EUDRACT 2016-001459-28) trial recruits patients with metastatic or unresectable…
Correction to: British Journal of Cancer (2016) 115, 789–796. doi:10.1038/bjc.2016.271 Upon publication of the above paper in the…
Kidney disease is a complication that is observed in 10%?30% of patients infected with human immunodeficiency virus (HIV), and is…
IMM-101 is an immunotherapeutic agent in clinical development as an adjunctive treatment in cancer. It comprises heat-killed…
Pancreatic cancer is an aggressive cancer with poor prognosis. Despite its low incidence, it is the 4th cause of cancer-related…
The tumour microenvironment is shaped by the interaction of tumour cells with a variety of “non” malignant cellular and acellular…